REN PINGDA 4
4 · Kura Oncology, Inc. · Filed Jan 24, 2019
Insider Transaction Report
Form 4
REN PINGDA
SVP, Chemistry
Transactions
- Award
Option to purchase common stock
2019-01-22+75,000→ 75,000 totalExercise: $15.47Exp: 2029-01-21→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments commencing on the grant date.